Cargando…

Norwegian patients on generic antihypertensive drugs: a qualitative study of their own experiences

OBJECTIVES: The aim of this study was to investigate experiences with and attitudes toward generic substitution in patients on antihypertensive medication. MATERIALS AND METHODS: Study participants were 22 patients from pharmacies in Oslo who had taken brand antihypertensive products as well as subs...

Descripción completa

Detalles Bibliográficos
Autores principales: Toverud, Else-Lydia, Røise, Anne Kjersti, Hogstad, Grete, Wabø, Inger
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016237/
https://www.ncbi.nlm.nih.gov/pubmed/21104408
http://dx.doi.org/10.1007/s00228-010-0935-x
_version_ 1782195698443223040
author Toverud, Else-Lydia
Røise, Anne Kjersti
Hogstad, Grete
Wabø, Inger
author_facet Toverud, Else-Lydia
Røise, Anne Kjersti
Hogstad, Grete
Wabø, Inger
author_sort Toverud, Else-Lydia
collection PubMed
description OBJECTIVES: The aim of this study was to investigate experiences with and attitudes toward generic substitution in patients on antihypertensive medication. MATERIALS AND METHODS: Study participants were 22 patients from pharmacies in Oslo who had taken brand antihypertensive products as well as substituted generic products. Five focus- group discussions were held. RESULTS: Only a few participants claimed to take their medications as prescribed. Most reported low drug adherence before and after generic substitution. Fourteen said that their blood pressure was not under control. Most patients did not know what it meant to get a generic product. They normally accepted what the pharmacy offered, even if they thought the generics were of a lower quality than the brand products. Five participants experienced new side effects. Differences in name, color, form, or taste caused confusion. The patients had been told in the pharmacy that the effect of a generic product was as good as that of the brand product but were still confused, as in most cases the doctor said nothing to them about the substitution. CONCLUSION: Generic substitution works well in Norway as an economic health strategy, but drug adherence remains suboptimal under those circumstances. Patients are insecure with respect to the difference between the old and the new product when it comes to the drug’s physical attributes and perceived quality. Patients would feel safer if the doctor had a more active role in informing them about the system.
format Text
id pubmed-3016237
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-30162372011-02-04 Norwegian patients on generic antihypertensive drugs: a qualitative study of their own experiences Toverud, Else-Lydia Røise, Anne Kjersti Hogstad, Grete Wabø, Inger Eur J Clin Pharmacol Pharmacoeconomics OBJECTIVES: The aim of this study was to investigate experiences with and attitudes toward generic substitution in patients on antihypertensive medication. MATERIALS AND METHODS: Study participants were 22 patients from pharmacies in Oslo who had taken brand antihypertensive products as well as substituted generic products. Five focus- group discussions were held. RESULTS: Only a few participants claimed to take their medications as prescribed. Most reported low drug adherence before and after generic substitution. Fourteen said that their blood pressure was not under control. Most patients did not know what it meant to get a generic product. They normally accepted what the pharmacy offered, even if they thought the generics were of a lower quality than the brand products. Five participants experienced new side effects. Differences in name, color, form, or taste caused confusion. The patients had been told in the pharmacy that the effect of a generic product was as good as that of the brand product but were still confused, as in most cases the doctor said nothing to them about the substitution. CONCLUSION: Generic substitution works well in Norway as an economic health strategy, but drug adherence remains suboptimal under those circumstances. Patients are insecure with respect to the difference between the old and the new product when it comes to the drug’s physical attributes and perceived quality. Patients would feel safer if the doctor had a more active role in informing them about the system. Springer-Verlag 2010-11-23 2011 /pmc/articles/PMC3016237/ /pubmed/21104408 http://dx.doi.org/10.1007/s00228-010-0935-x Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Pharmacoeconomics
Toverud, Else-Lydia
Røise, Anne Kjersti
Hogstad, Grete
Wabø, Inger
Norwegian patients on generic antihypertensive drugs: a qualitative study of their own experiences
title Norwegian patients on generic antihypertensive drugs: a qualitative study of their own experiences
title_full Norwegian patients on generic antihypertensive drugs: a qualitative study of their own experiences
title_fullStr Norwegian patients on generic antihypertensive drugs: a qualitative study of their own experiences
title_full_unstemmed Norwegian patients on generic antihypertensive drugs: a qualitative study of their own experiences
title_short Norwegian patients on generic antihypertensive drugs: a qualitative study of their own experiences
title_sort norwegian patients on generic antihypertensive drugs: a qualitative study of their own experiences
topic Pharmacoeconomics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016237/
https://www.ncbi.nlm.nih.gov/pubmed/21104408
http://dx.doi.org/10.1007/s00228-010-0935-x
work_keys_str_mv AT toverudelselydia norwegianpatientsongenericantihypertensivedrugsaqualitativestudyoftheirownexperiences
AT røiseannekjersti norwegianpatientsongenericantihypertensivedrugsaqualitativestudyoftheirownexperiences
AT hogstadgrete norwegianpatientsongenericantihypertensivedrugsaqualitativestudyoftheirownexperiences
AT wabøinger norwegianpatientsongenericantihypertensivedrugsaqualitativestudyoftheirownexperiences